Patents Assigned to ECP Pharma
  • METHODS OF TREATMENT WITH COMBINATIONS OF CANNABIDIOL AND PSILOCYBIN
    Publication number: 20240156843
    Abstract: The disclosure relates to methods for treating brain injuries that include administering to a patient a first dosage of about 100 mg to about 500 mg of cannabidiol (CBD) and administering to the patient, concomitantly with the first dosage, a second dosage of about 1 to about 10 milligrams of Psilocybin.
    Type: Application
    Filed: January 19, 2024
    Publication date: May 16, 2024
    Applicant: ECP Pharma
    Inventors: Nitin ANAND, Michael E. HOFFER, Moiz RANGWALLA, Andy MERA, Gilberto IRAGORRI
  • Methods of treatment with combinations of cannabidiol and psilocybin
    Patent number: 11911402
    Abstract: The disclosure relates to methods for treating brain injuries that include administering to a patient a first dosage of about 100 mg to about 500 mg of cannabidiol (CBD) and administering to the patient, concomitantly with the first dosage, a second dosage of about 1 to about 10 milligrams of Psilocybin.
    Type: Grant
    Filed: October 12, 2022
    Date of Patent: February 27, 2024
    Assignee: ECP Pharma
    Inventors: Nitin Anand, Michael E. Hoffer, Moiz Rangwalla, Andy Mera, Gilberto Iragorri
  • METHODS OF TREATMENT WITH COMBINATIONS OF CANNABIDIOL AND PSILOCYBIN
    Publication number: 20230112459
    Abstract: The disclosure relates to methods for treating brain injuries that include administering to a patient a first dosage of about 100 mg to about 500 mg of cannabidiol (CBD) and administering to the patient, concomitantly with the first dosage, a second dosage of about 1 to about 10 milligrams of Psilocybin.
    Type: Application
    Filed: October 12, 2022
    Publication date: April 13, 2023
    Applicant: ECP Pharma
    Inventors: Nitin ANAND, Michael E. HOFFER, Moiz RANGWALLA, Andy MERA, Gilberto IRAGORRI